TGM2 and cancer: TG2, a GTP/GDP-binding protein, hydrolyzes GTP and functions as a G protein and it is now recognized as a key cancer cell survival factor that interacts with signaling pathways that drive vital cancer-related functions, including drug resistance, cancer stem cell survival, metastasis, inflammation, epithelial‒mesenchymal transition, and angiogenesis [16, 17].